PURE Bioscience Hosts Q2 Results Conference Call March 4, 2015 to Review Progress of SDC-Based Food Safety Solutions Strategy
(firmenpresse) - SAN DIEGO, CA -- (Marketwired) -- 02/24/15 -- (OTCQB: PURE), creator of the patented silver dihydrogen citrate () antimicrobial, announced today that the Company will host an investor conference call on Wednesday, March 4, 2015 at 1:30pm PST (4:30pm EST).
In addition to discussion of second fiscal quarter 2015 results, the will review the progress made to commercialize SDC as a food safety solution.
The Participant Dial-In Number for the conference call is 1-631-982-4565. Participants should dial in to the call at least five minutes before 1:30pm PST (4:30pm EST) on March 4, 2015. The call can also be accessed "live" online at .
A replay of the webcast will be available on the Company's website (). Also, a replay of the conference call will be available by dialing 1-877-870-5176 (international participants dial 1-858-384-5517) starting March 4, 2015, at 7:30pm Eastern Time through March 18, 2015 at 11:59 pm Eastern Time. Please use PIN Number 90304.
PURE Bioscience, Inc. is focused on developing and commercializing our proprietary antimicrobial products primarily in the food safety arena -- providing solutions to the health and environmental challenges of pathogen and hygienic control. Our technology platform is based on patented stabilized ionic silver, and our initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection and formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at .
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the Company's cash position and liquidity requirements; the Company's failure to implement or otherwise achieve the benefits of its proposed business initiatives and plans; acceptance of the Company's current and future products and services in the marketplace, including acceptance of the Company's PURE Hard Surface disinfectant by SUBWAY® franchisees; the ability of the Company to develop effective new products and receive regulatory approvals of such products, including the required regulatory approvals to use its SDC-based technology as a direct food contact processing aid; competitive factors; dependence upon third-party vendors, including to manufacture its products; and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission, including our quarterly report on Form 10-Q filed on December 11, 2014. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
Peter C. Wulff
CFO & COO
PURE Bioscience, Inc.
619-596-8600 ext.111
Terri MacInnis
VP of IR
Bibicoff + MacInnis, Inc.
818-379-8500
Tom Hemingway
Redwood Investment Group
714-978-4425
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 24.02.2015 - 13:31 Uhr
Sprache: Deutsch
News-ID 373733
Anzahl Zeichen: 0
contact information:
Town:
SAN DIEGO, CA
Kategorie:
Specialty Chemicals
Diese Pressemitteilung wurde bisher 225 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"PURE Bioscience Hosts Q2 Results Conference Call March 4, 2015 to Review Progress of SDC-Based Food Safety Solutions Strategy"
steht unter der journalistisch-redaktionellen Verantwortung von
PURE Bioscience, Inc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
